Aerobic exercise training in heart failure: impact on sympathetic hyperactivity and cardiac and skeletal muscle

P C Brum1, A V N Bacurau, A Medeiros

  • 1Departamento de Biodinâmica do Movimento do Corpo Humano, Escola de Educação Física e Esporte, Universidade de São Paulo, Brasil. pcbrum@usp.br

Insights

Aerobic exercise training effectively combats sympathetic hyperactivity in heart failure. This approach improves cardiac function, reduces skeletal myopathy, and aids cardiac remodeling in both humans and animals.

Area of Science:

  • Cardiovascular Disease Research
  • Exercise Physiology
  • Heart Failure Pathophysiology

Background:

  • Heart failure is a major cause of death, characterized by chronic sympathetic hyperactivity.
  • Sympathetic hyperactivity worsens cardiac dysfunction, remodeling, and skeletal muscle issues in heart failure.
  • This hyperactivity is linked to poor prognosis in cardiovascular disease.

Purpose of the Study:

  • To review the impact of aerobic exercise on sympathetic hyperactivity in heart failure.
  • To examine exercise's effects on cardiac function, remodeling, and skeletal myopathy.
  • To explore the underlying mechanisms of aerobic exercise's benefits in heart failure.

Main Methods:

  • Literature review of studies on aerobic exercise training in human and animal models of heart failure.
  • Analysis of research focusing on neurohumoral excitation and its markers.
  • Examination of data on cardiac structure, function, and skeletal muscle pathology.

Main Results:

  • Aerobic exercise training significantly counteracts sympathetic hyperactivity in heart failure.
  • Exercise improves cardiac function and mitigates adverse cardiac remodeling.
  • Skeletal myopathy associated with heart failure is ameliorated by aerobic exercise.

Conclusions:

  • Aerobic exercise is a viable strategy to manage sympathetic hyperactivity in heart failure.
  • Exercise training offers multifaceted benefits, improving cardiac and skeletal muscle health.
  • Understanding exercise mechanisms can optimize heart failure treatment protocols.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Exercise and Cardiac Output01:17

Exercise and Cardiac Output

Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be met...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...